By: P.T., STA
The Krka group posted EUR 432.5 million in sales revenue in the first quarter of the year, up 9% year-on-year.
Net profit rose by 5% to EUR 90.7 million, the highest ever for a first quarter, the drug maker said. Sales were increased in all six sales regions and in most of the company’s key markets, as well as in all product and service groups,” said Jože Colarič, Krka’s CEO. Accounting for a third of total sales or EUR 146.7 million, the group’s largest sales region was East Europe, where turnover increased by 11%. The AGM will be held on 7 July, and a higher dividend payout has been proposed.